ScopeSys uses AI to accelerate genomic medicine research
TL;DR. ScopeSys develops next-generation analytical instruments that leverage AI to observe individual RNA and DNA molecules for drugmakers. - The company's Convex Lens-induced Confinement (CLiC) technology provides particle-by-particle insights into complex therapies. - ScopeSys applies AI across its operations, from scientific research acceleration to market analysis and decision-making. - This AI integration helps the 7-person team operate with the speed and breadth of a larger organization.
- ScopeSys develops analytical instruments for genomic medicine research.
- Their CLiC technology offers molecule-level insights into RNA and DNA.
- AI is integral to ScopeSys's internal operations and scientific research acceleration.
- The company secured